Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials.

Slides:



Advertisements
Similar presentations
CHRONIC SPECIFIC INFLAMMATION
Advertisements

Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Morphologic Features of Melanophages Under In Vivo.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis.
Optimizing Diagnosis From the Medical Liver Biopsy
Copyright © 2010 American Medical Association. All rights reserved.
Digestive pathology 2.
Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation  Qing Ma, Dan Li, Roza Nurieva, Rebecca.
Increase in FOXP3+ Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response  Cristina Fondi, Chiara Nozzoli,
by Görgün Akpek, John K. Boitnott, Linda A. Lee, Jason P
A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus- Host Disease (cGVHD) Therapeutic Response Measures: Feasibility,
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical.
Clinical Evaluation of Oral Chronic Graft-Versus-Host Disease
The Use of Immunoglobulin G4 Immunostaining in Diagnosing Pancreatic and Extrapancreatic Involvement in Autoimmune Pancreatitis  Maesha G. Deheragoda,
Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation  Javier.
The Use of Immunoglobulin G4 Immunostaining in Diagnosing Pancreatic and Extrapancreatic Involvement in Autoimmune Pancreatitis  Maesha G. Deheragoda,
A Canine Model of Chronic Graft-versus-Host Disease
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging.
A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus- Host Disease (cGVHD) Therapeutic Response Measures: Feasibility,
Optimizing Diagnosis From the Medical Liver Biopsy
David Myerson, Gideon Steinbach, Ted A. Gooley, Howard M. Shulman 
Fatal Hyperacute Graft-versus-Host Disease following Denileukin Diftitox Treatment for Recurrent T Cell Lymphoma after Allogeneic Stem Cell Transplantation 
Development of a reticular rash in a febrile woman: An unusual cutaneous presentation of angioimmunoblastic T-cell lymphoma  Michelle S. Min, MSci, Jonathan.
Voriconazole-Induced Phototoxicity Masquerading as Chronic Graft-versus-Host Disease of the Skin in Allogeneic Hematopoietic Cell Transplant Recipients 
Sympathectomy Protects Denervated Skin from Graft-Versus-Host Disease
Maya Srivastava, Antonio Perez–Atayde, Maureen M. Jonas 
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis.
Yngvar Fløisand, Knut E. A
Salivary Gland Involvement in Chronic Graft-Versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation  Matin M. Imanguli,
Graft-versus-Host Disease–Related Cytokine-Driven Apoptosis Depends on p73 in Cytokeratin 15–Positive Target Cells  Qian Zhan, Robert Korngold, Cecilia.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker.
Keratinocyte Dysplasia in Hematopoietic Stem Cell Transplantation Recipients in the Day-28-to-84 Posttransplantation Period  Ning Li, Katherine A. Guthrie,
Genital Chronic Graft-versus-Host Disease in Females: A Cross-Sectional Study  Eva Smith Knutsson, Yvonne Björk, Anna-Karin Broman, Lotti Helström, Anne-Marie.
Sequential Expression of Adhesion and Costimulatory Molecules in Graft-versus-Host Disease Target Organs after Murine Bone Marrow Transplantation across.
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis  William R Kessler, Oscar W Cummings, George Eckert, Naga Chalasani,
Histological Assessment of the Sclerotic Graft-versus-Host Response in the Humanized RAG2−/−γc−/− Mouse Model  Marieke C.H. Hogenes, Suzanne van Dorp,
Limbus Damage in Ocular Graft-versus-Host Disease
Cutaneous Manifestations of Chronic Graft-versus-Host Disease
Volume 141, Issue 5, Pages e9 (November 2011)
Histologic Features of the Liver Biopsy Predict the Clinical Outcome for Patients with Graft-versus-Host Disease of the Liver  Rafael F. Duarte, Julio.
Pulmonary Arterial Hypertension in Pediatric Patients with Hematopoietic Stem Cell Transplant–Associated Thrombotic Microangiopathy  Sonata Jodele, Russel.
Evidence of a Graft-versus-Hodgkin Lymphoma Effect in the Setting of Extensive Bone Marrow Involvement  Paolo Anderlini, MD  Biology of Blood and Marrow.
Extracorporeal Photopheresis in Steroid-Refractory Acute or Chronic Graft-versus-Host Disease: Results of a Systematic Review of Prospective Studies 
Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft- versus-Host Disease  Scott S. Graves, Maura H. Parker, Diane Stone,
Chronic graft-versus-host disease
Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life
Clinical Benefit of Response in Chronic Graft-versus-Host Disease
Lisa A. Palmer, George E. Sale, John I
Comparison of Short-Term Response and Long-Term Outcomes after Initial Systemic Treatment of Chronic Graft-Versus-Host Disease  Paul J. Martin, Barry.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary.
Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases?  Sowmya Kishor, MD, Maria L. Turner, MD, Brian B. Borg,
Late-Onset Colitis after Cord Blood Transplantation Is Consistent with Graft-Versus-Host Disease: Results of a Blinded Histopathological Review  Filippo.
Oral Chronic Graft-versus-Host Disease Scoring Using the NIH Consensus Criteria  Nathaniel S. Treister, Kristen Stevenson, MS, Haesook Kim, Sook-Bin Woo,
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease
Betty K. Hamilton, Lisa Rybicki, Sally Arai, Mukta Arora, Corey S
Paul J. Martin, Terry Furlong, Scott D. Rowley, Steven A
Eosinophilic Granuloma of the Lung
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease 
Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical.
T-Cell Receptor Vα Spectratype Analysis of a CD4-Mediated T-Cell Response against Minor Histocompatibility Antigens Involved in Severe Graft-versus-Host.
Unrelated Stem Cell Transplantation after a Reduced Intensity Conditioning Regimen Containing High-Dose Thymoglobulin Leads to Controllable Graft-versus-Host.
John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos 
Update on Graft versus Host Disease
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial 
Acute graft-versus-host disease arising within tattooed skin
Alveolar Hemorrhage and Acute Graft-versus-Host Disease
Prospective Monitoring of Tumor Necrosis Factor α and Interferon γ to Predict the Onset of Acute and Chronic Graft-versus-Host Disease after Allogeneic.
Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes.
Mary Eapen  Biology of Blood and Marrow Transplantation 
Volume 5, Issue 7, Pages (July 2019)
Presentation transcript:

Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft- versus-Host Disease: II. Pathology Working Group Report  Howard M. Shulman, David Kleiner, Stephanie J. Lee, Thomas Morton, Steven Z. Pavletic, Evan Farmer, J. Margaret Moresi, Joel Greenson, Anne Janin, Paul J. Martin, George McDonald, Mary E.D. Flowers, Maria Turner, Jane Atkinson, Jay Lefkowitch, M. Kay Washington, Victor G. Prieto, Stella K. Kim, Zsolt Argenyi, A. Hafeez Diwan, Asif Rashid, Kim Hiatt, Dan Couriel, Kirk Schultz, Sharon Hymes, Georgia B. Vogelsang  Biology of Blood and Marrow Transplantation  Volume 12, Issue 1, Pages 31-47 (January 2006) DOI: 10.1016/j.bbmt.2005.10.023 Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Hepatic GVHD. A, Late onset of acute GVHD, day 123. The expanded portal space contains a mixed infiltrate of lymphocytes and scattered eosinophils. The interlobular bile duct shows destructive changes of GVHD with infiltration by lymphocytes, segmental loss of nuclei, cytoplasmic vacuolization, and nuclear dyspolarity. Ductular proliferation at the margins of the portal space also shows some features of GVHD (original magnification, ×250). B, Refractory chronic GVHD, day 556. Interlobular bile ducts have a characteristic withered appearance with dyspolarity, dropout of nuclei, nuclear enlargement, anisonucleosis, infiltrating lymphocytes, and eosinophilia of the cytoplasm. The fibrotic portal space contains scattered lymphoid cells, and periportal hepatocytes show changes of chronic cholestasis with cytoplasmic ballooning (original magnification, ×250). C, Refractory untreated chronic GVHD, day 350. Portal spaces have marked ductopenia with a loss of bile ducts, a lymphoplasmacytic infiltrate, and fibrosis with focal bridging (not shown; original magnification, ×250). Biology of Blood and Marrow Transplantation 2006 12, 31-47DOI: (10.1016/j.bbmt.2005.10.023) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Gastrointestinal GVHD. A, Persistent GVHD in the colon, day 87. The colonic biopsy specimen has numerous contiguous apoptotic changes (arrows; original magnification, ×250). B, Late acute GVHD in the stomach, day 133. The biopsy sample shows pronounced lymphocytic and prominent eosinophilic infiltration with destruction of gastric antral glands and formation of crypt abscesses (original magnification, ×250). Biology of Blood and Marrow Transplantation 2006 12, 31-47DOI: (10.1016/j.bbmt.2005.10.023) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Progression of histologic changes from acute to chronic cutaneous GVHD. A, Screening skin biopsy, day 85. A focal apoptotic body formation is present at the tips of rete ridges (arrow) with focal surrounding lymphocytic satellitosis (original magnification, ×400). B, Lichen planus–like chronic GVHD, day 426. The thickened epidermis displays orthokeratosis, hypergranulosis, and acanthosis. The striking lichenoid reaction along the damaged basal layer includes a prominent lymphocytic inflammation and infiltration, apoptotic changes, loss of rete ridges, and prominence of the superficial vascularity (original magnification, ×100). C, Progression of GVHD from panel A into a sclerotic stage, day 382. A zone of dense, relatively avascular homogenized collagen has replaced the papillary and upper reticular dermis (original magnification, ×63). D, High-power view shows a hyperkeratotic epidermis with flattening of the rete ridges, vacuolar changes, and lymphocytic infiltration along the basal layer, with disruption of the epidermal melanin unit and with coarse clumps of melanin in the epidermis and incontinent melanin pigment in the sclerotic papillary dermis (original magnification, ×160). Biology of Blood and Marrow Transplantation 2006 12, 31-47DOI: (10.1016/j.bbmt.2005.10.023) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Morpheic GVHD lesion, day 607. A, Low power shows a thickened dermis with sclerotic widening of the lower reticular dermis and fascia (original magnification, ×20). B, The epidermis shows activity of GVHD with scattered apoptotic bodies. Note that the papillary dermis is not sclerotic, in contrast to the deep dermis and fascia in panel D (original magnification, ×400). C, Syringitis: eccrine coils are infiltrated by lymphocytes with a loss of adjacent fat tissue replaced by fibrous tissue (original magnification, ×200). D, Interface of the reticular dermis and the fascia shows fasciitis with fibrous thickening of the septa, lymphocytic panniculitis, and formation of lymphoid follicles (original magnification, ×63). Biology of Blood and Marrow Transplantation 2006 12, 31-47DOI: (10.1016/j.bbmt.2005.10.023) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 Oral GVHD. A, Oral mucosal biopsy sample, day 75. This view shows lymphocytic infiltrate along the basal layer of the mucosa (original magnification, ×160). B, High-powered view shows apoptotic changes along the tip of a rete ridge (arrow; original magnification, ×400). C, Minor salivary gland, day 364. Early lobular involvement shows focal periductal lymphocytic infiltrates with minimal loss of acinar tissue (original magnification, ×63). D, High-powered view of an intralobular duct with marked lymphocytic infiltration, cytoplasmic vacuolization, and focal destruction of the ductular epithelium (original magnification, ×160). Biology of Blood and Marrow Transplantation 2006 12, 31-47DOI: (10.1016/j.bbmt.2005.10.023) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 6 Pulmonary GVHD with obliterative bronchiolitis: lung biopsy specimen, day 194. A small airway shows constriction of the bronchiole lumen by a subepithelial expansion of fibrous tissue. A lymphocytic infiltrate surrounds the outer bronchiole smooth muscle layer (original magnification, ×250; photo courtesy of Dr. Robert Hackman, of Fred Hutchinson Cancer Research Center). Biology of Blood and Marrow Transplantation 2006 12, 31-47DOI: (10.1016/j.bbmt.2005.10.023) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions